FDA Approves First LAG 3 Inhibitor Antibody Opdualag For Metastatic Melanoma
22 mars 2022 03h28 HE
|
KuicK Research
Delhi, March 22, 2022 (GLOBE NEWSWIRE) -- Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028 Report Highlights: Global LAG 3 Inhibitors Market Dynamics Clinical...
LAG 3 Inhibitor Clinical Trials Research Intelligence
21 déc. 2021 03h38 HE
|
KuicK Research
Delhi, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Global LAG 3 Inhibitors Trials Intelligence Report Highlights: Global LAG 3 Inhibitors Market DynamicsClinical Approaches to Target LAG 3 InhibitorsRole...
Immutep Operational Update
15 déc. 2020 08h00 HE
|
Immutep Limited
Efti clinical trial status updatesExcellent financial position following recent US$7.7 million warrant exercise, with cash runway extended beyond end of calendar year 2022 Sydney, AUSTRALIA, Dec. ...